Selective inhibition of human translation termination by a drug-like compound
The drug-like compound PF846 and its derivatives inhibit the translation of specific mRNAs by the human ribosome. Here the authors show how PF846 arrests translation at the stop codon by slowing hydrolysis of the protein nascent chain at the ribosome P-site tRNA by eukaryotic release factor 1 (eRF1)...
Saved in:
Main Authors: | Wenfei Li, Stacey Tsai-Lan Chang, Fred. R. Ward, Jamie H. D. Cate |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/b86e399a4ec045d89db7d9e3ea9c2b22 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition
by: Dmitrii Y. Travin, et al.
Published: (2019) -
Mechanisms of drug interactions between translation-inhibiting antibiotics
by: Bor Kavčič, et al.
Published: (2020) -
Structural basis of suppression of host translation termination by Moloney Murine Leukemia Virus
by: Xuhua Tang, et al.
Published: (2016) -
Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor
by: Jacky K. Leung, et al.
Published: (2021) -
Translational coupling via termination-reinitiation in archaea and bacteria
by: Madeleine Huber, et al.
Published: (2019)